Meyka AI API is live for developers.Start building.
Advertisement
Hancock Jaffe Laboratories

Hancock Jaffe Laboratories (HJLI) Stock Overview

Explore Hancock Jaffe Laboratories’s financial performance, market position, analyst ratings, and future outlook.

HJLI●NASDAQ
HealthcareMedical - Devices
$10.38
$0.21(1.98%)
U.S. Market opens in 52h 1m
Advertisement

Hancock Jaffe Laboratories (HJLI)

Meyka AI Score

Z

Key Financials

Market Cap98.3M
P/E Ratio-0.27
EPS (TTM)N/A
ROE-0.66%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

HJLI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Hancock Jaffe Laboratories (HJLI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.27 and a market capitalization of 98.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
99.23%
3-Year Change
-44.79%
5-Year Change
-92.08%
All-Time (Max) Change
-92.08%

Contact Information

http://www.hancockjaffe.com
19492612900
70 Doppler, Irvine, CA, 92618

Company Facts

190 Employees
IPO DateMay 31, 2018
CountryUS

Frequently Asked Questions